CGON's three largest insider shareholders as of March 23, 2026 are Capital Global Life Sciences Fund Iv, L.P. Decheng (TenPercentOwner, 4.96Mn shares), Hong Fang Song (Director, 2.90Mn shares), Brian Guan-Chyun Liu (Director, 1.52Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Global Life Sciences Fund Iv, L.P. Decheng | 4,958,810 | 0 | 09 Apr, 2024 | |
| Hong Fang Song | 0 | 2,903,931 | 04 Sep, 2025 | |
| Brian Guan-Chyun Liu | 0 | 1,515,151 | 12 Sep, 2025 | |
| Hong Fang Song | 613,928 | 0 | 31 Jan, 2024 | |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | 0 | 400,000 | 31 Jan, 2024 | |
| Arthur Kuan | Chief Executive Officer | 198,916 | 0 | 13 Mar, 2026 |
| Corleen M. Roche | Cfo Secretary | 2,000 | 0 | 31 Jan, 2024 |
| Vijay Kasturi | Chief Medical Officer | 1,315 | 0 | 31 Jan, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | James Mulay | Common Stock | A | 654 | $3.72 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 654 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Common Stock | A | 1,310 | $12.59 | 1,310 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 1,310 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 654 | $0.00 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 1,310 | $0.00 | 3,930 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | D | 1,847 | $60.15 | 198,916 | D | F |
| 12 Mar, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | D | 64,612 | $0.00 | 0 | D | M |
| 04 Mar, 2026 | Arthur Kuan | Common Stock | A | 102,871 | $1.72 | 139,022 | D | M |
| 04 Mar, 2026 | Arthur Kuan | Common Stock | D | 2,871 | $61.61 | 136,151 | D | F |
| 04 Mar, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | D | 102,871 | $0.00 | 64,612 | D | M |
| 09 Jan, 2026 | James Mulay | Common Stock | A | 654 | $3.72 | 654 | D | M |
| 09 Jan, 2026 | James Mulay | Common Stock | D | 654 | $44.16 | 0 | D | S |
| 09 Jan, 2026 | James Mulay | Common Stock | A | 10,491 | $12.59 | 10,491 | D | M |
| 09 Jan, 2026 | James Mulay | Common Stock | D | 10,491 | $52.99 | 0 | D | S |
| 09 Jan, 2026 | James Mulay | Director Stock Option (right to buy) | D | 654 | $0.00 | 1,308 | D | M |
| 09 Jan, 2026 | James Mulay | Director Stock Option (right to buy) | D | 10,491 | $0.00 | 5,240 | D | M |
| 24 Nov, 2025 | Christina Rossi | Director Stock Option (right to buy) | A | 20,889 | $0.00 | 20,889 | D | A |
| 17 Nov, 2025 | Leonard E Post | Common Stock | A | 1,000 | $0.60 | 1,000 | D | M |